Skip to content

Inflammatory Biomarkers of Pediatric Pulmonary Hypertension

Inflammatory Biomarkers of Pediatric Pulmonary Hypertension: a Prospective Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03581695
Enrollment
74
Registered
2018-07-10
Start date
2018-06-20
Completion date
2024-07-01
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Pulmonary

Brief summary

To investigate if the inflammatory protein, high mobility group box 1 (HMGB1), along with other inflammatory mediators, is elevated in pediatric patients with congenital heart disease (CHD) and pulmonary hypertension as compared to those with CHD alone, or with healthy controls.

Interventions

OTHERBlood test

Blood test

Sponsors

The Hospital for Sick Children
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 18 Years
Healthy volunteers
Yes

Inclusion criteria

-patients of any age with congenital cardiac disease coming for catheterization of the right heart, or both the right and left heart.

Exclusion criteria

* active systemic infection * current active cancer * active cancer treatment * prior bone marrow transplant * prior solid organ transplant

Design outcomes

Primary

MeasureTime frameDescription
Measurement of HGMB11 dayMeasurement of HGMB1

Countries

Canada

Contacts

PRINCIPAL_INVESTIGATORKatherine Taylor

The Hospital for Sick Children

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 5, 2026